%0 Journal Article
%T Use of Hepatitis B Virus-Positive Organs in Organ Transplantation.
%A Khemichian S
%A Kahn J
%A Terrault NA
%J Clin Liver Dis
%V 25
%N 4
%D 11 2021
%M 34593157
%F 6.265
%R 10.1016/j.cld.2021.06.009
%X The significant morbidity and mortality of people with end-stage renal, liver, heart, and lung diseases in need of transplantation provides rationale for use of organs from donors who are hepatitis B positive. The recipient's hepatitis B status plays a key role in defining the prophylactic strategy. The availability of safe and effective therapies (hepatitis B antivirals and hepatitis B immune globulin) has contributed to the safety of using hepatitis B-positive donors. The outcomes in both liver and nonliver solid organ transplant recipients given hepatitis B-positive organs have been excellent if appropriate prophylactic therapies provided.